(71b) Can Laboratory Automation Finally Fulfill the Promise of Revolutionizing Pharmaceutical Discovery?
- Conference: AIChE Annual Meeting
- Year: 2017
- Proceeding: 2017 AIChE Annual Meeting
- Group: Pharmaceutical Discovery, Development and Manufacturing Forum
Monday, October 30, 2017 - 8:50am-9:35am
From Bruce Merrifieldâs pioneering work in the automation of peptide synthesis in the 60âs to the boom and bust of combinatorial chemistry in the 90âs, laboratory automation technology for chemical synthesis in early stage drug discovery research has played a role of both hero and villain. This lecture will unearth insights into this rich history and will detail Lillyâs research experience with discovery-scale laboratory automation. A specific emphasis will be on our more than a decade of experience with our one of a kind remote access fully integrated Automated Synthesis Laboratory (ASL). Discussion of the key learnings, successes, and challenges in our ASL experience will serve as the backdrop for a bold new vision for the future of remote access, fully integrated laboratory science. The audience will learn about Lillyâs ongoing investment in the construction of the Lilly Life Sciences Studio (L2S2), which we believe will significantly change pharmaceutical research in both industry and academia.